REGENXBIO Inc.
RGNX· Nasdaq
RGNXREGENXBIO Inc.
Filed May 5, 2016 · 10-Q · 35 days after period end · 0001564590-16-017818
| Metric | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|
| Revenue | $393.00K | $644.00K | $2.94M |
| Net Income | -$10.77M | -$4.01M | $795.00K |
| EPS Diluted | -$0.41 | -$0.94 | $0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
REGENXBIO Inc. · CIK 1590877 · Engraved from SEC EDGAR
ended Mar 31, 2016 · filed May 5, 2016 · 35 d after period end
